Rampart Duo Clinical (RaDical) Post-Market Study
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03974711. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Rampart Duo Clinical (RaDical) Study: An Exempt Minimal Risk Post-Market Evaluation of Clinical Outcomes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This exempt, minimal risk, prospective, post-market, registry, multi-center, Institution Review Board (IRB) approved observational clinical evaluation was conducted at 10 centers. A total of 197 patients were enrolled. The evaluation collected data in a real-world patient population and was a data collection initiative only. No patient treatments or care were performed as a component of the protocol. All patient care received was on-label and standard of care for lateral lumbar interbody fusions. The data collected in this evaluation is intended to contribute to the body of literature for lateral lumbar interbody fusions.
Study identification
- NCT ID
- NCT03974711
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 197 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2, 2017 (Actual)
- Primary completion
- Apr 21, 2022 (Actual)
- Completion
- Oct 3, 2022 (Actual)
- Last update posted
- Dec 1, 2023
2017 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bell Neuroscience Institute/Washington Township Medical Foundation | Fremont | California | 94538 | — |
| Loma Linda University | Loma Linda | California | 92354 | — |
| Napa Valley Orthopaedic Medical Group | Napa | California | 94558 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20734 | — |
| South Florida Spine & Orthopedics | Coconut Creek | Florida | 33073 | — |
| Orthopaedic Institute of Western Kentucky | Paducah | Kentucky | 42001 | — |
| Spine Institute of Louisiana | Shreveport | Louisiana | 71101 | — |
| Orthopedic Institute of Pennsylvania | Camp Hill | Pennsylvania | 17011 | — |
| Austin Spine Specialists | Austin | Texas | 78705 | — |
| Spine Works Institute | North Richland Hills | Texas | 76182 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03974711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2023 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.